跳至主要内容
临床试验/NCT01237171
NCT01237171撤回不适用

Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC

IsoRay Medical, Inc.1 个研究点 分布在 1 个国家开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Local Recurrence

研究概览

简要总结

For patients diagnosed with early (Stage I) non-small cell lung cancer, a lobe of lung is usually removed at surgery to treat the cancer. For some patients, the removal of a lobe of lung may leave too little lung behind for easy breathing. For some of these patients, it may be possible to perform a smaller-scale surgery ("sub-lobar resection") and place a radioactive implant behind to prevent the cancer from growing back. This study will see how these patients do in terms of controlling their disease treated with a radioactive implant called Cesium-131.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients must have suspicious lung nodule for clinical stage I/recurrent non-small cell Lung Cancer
  • Mass Tumor size < 7 cm
  • Patient must have a CT scan of the chest with upper abdomen within 90 days prior to date of pre-registration.
  • Patient must have ECOG/Zubrod performance status 0,1, or 2.

排除标准

  • Patient has already received high dose radiation to the area
  • Cancerous nodule is very close to the esophagus or spinal cord, thereby increasing the risk of radiation treatment
  • Pregnancy or unwillingness to practice a form of birth control (i.e. abstinence, oral contraceptives, etc.)

结局指标

主要结局

Local Recurrence

时间窗: 3 Years

Cancer regrowth in the area where it was surgically removed

次要结局

  • Quality of Life(2 years)

研究者

发起方
IsoRay Medical, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验